Cargando…
Pharmacokinetics of convalescent plasma therapy in a COVID-19 patient with X-linked Agammaglobulinemia
Convalescent plasma (CP) has been the first line of defense against numerous infectious diseases throughout history. The COVID-19 pandemic created a need for a quick, easily accessible, and effective treatment for severe disease and CP was able to meet that immediate need. The utility of CP warrants...
Autores principales: | Yates, Jennifer L., Palat, David S., Subik, M. Kristina, Lee, William T., McDonough, Kathleen A., Conuel, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907110/ http://dx.doi.org/10.1016/j.clicom.2022.03.001 |
Ejemplares similares
-
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
por: Jin, Haoli, et al.
Publicado: (2020) -
A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma
por: Iaboni, Aled, et al.
Publicado: (2021) -
Tubulointerstitial nephritis complicating IVIG therapy for X-linked agammaglobulinemia
por: Sugimoto, Keisuke, et al.
Publicado: (2014) -
Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma
por: Mira, Estefanía, et al.
Publicado: (2020) -
Astrovirus Encephalitis in Boy with X-linked Agammaglobulinemia
por: Quan, Phenix-Lan, et al.
Publicado: (2010)